Emmanuel C. Opara, PhD, received his [...] degree in Clinical Biochemistry at the University of Surrey in England and a Ph.D. in Medical Biochemistry from the University of London. After a WHO-sponsored research fellowship in Endocrinology/Metabolism at the Mayo Clinic in Rochester, MN he was a visiting fellow at the NIDDK, NIH in Bethesda, MD before spending 15 years on faculty at the Duke University Medical Center in Durham, NC. He subsequently was a research professor in the Biomedical Engineering program at the Illinois Institute of Technology, Chicago while serving as a senior investigator in the Human Islet Transplant program at the University of Chicago. He accepted his present position as a professor at the Wake Forest Institute for Regenerative Medicine (WFIRM) in 2009 and currently serves as a professor in the Center on Obesity, Diabetes & Metabolism at the Wake Forest School of Medicine. He also serves as professor and graduate program director at the Wake Forest University campus in Winston-Salem, NC of the joint Virginia Tech-Wake Forest School of Biomedical Engineering & Sciences (SBES). Dr. Opara is a member of many professional organizations including the American Diabetes Association, American Federation for Medical Research, and the American Pancreatic Association. He was honored by the Society of Black Academic Surgeons with a distinguished service award in 2007.

Sam Dagogo-Jack, MD is Professor of Medicine and Chief of the Division of Endocrinology, Diabetes and Metabolism at the University of Tennessee Health Science Center, Memphis, TN, where he holds the A. C. Mullins Endowed Professorial Chair in Translational Research and also serves as Director of the General Clinical Research Center at UTHSC. Dr. Dagogo-Jack's current research focuses on the interaction of genetic and environmental factors in the prediction and prevention of prediabetes and diabetes. He is a Principal Investigator of the Diabetes Prevention Program Outcomes Study (DPPOS), the Epidemiology of Diabetes Interventions and Complications (EDIC) study, and the Pathobiology and Reversibility of Prediabetes in a Biracial Cohort (PROP-ABC) study, all funded by the National Institutes of Health. A recipient of the Distinction in Endocrinology Award from the American College of Endocrinology, Dr. Dagogo-Jack treats patients with diabetes, endocrine, and metabolic disorders and also directs the Endocrinology Fellowship Training Program at UTHSC.

Section i Pathophysiology and treatment of obesity Chapter 1Central and Peripheral Modulators of Appetite and Satiety Chapter 2Genetic Determinants of Nutrient Processing Chapter 3The Enteroinsular Axis: Contribution to Obesity-Diabetes and Its Treatments Chapter 4Metabolic Syndrome: Recognition, Etiology, and Physical Fitness as a Component Chapter 5Fat Distribution and Diabetes Mellitus Chapter 6Combined Effect of Diet and Physical Activity in the Management of Obesity Chapter 7Pharmacological Treatment of Obesity Chapter 8The Role of Gut Microbiota in the Pathogenesis and Treatment of Obesity Chapter 9Bariatric Surgery Chapter 10Postoperative Nutritional Management of the Bariatric-Surgery Patient Section ii Pathophysiology and treatment of Diabetes Chapter 11Health and Economic Burdens of Diabetes and Its Complications Chapter 12Nutrient Interactions and Glucose Homeostasis Chapter 13Management of Obesity-Associated Type 2 Diabetes Chapter 14Type 2 Diabetes in Childhood: Diagnosis, Pathogenesis, Prevention, and Treatment Chapter 15The Contribution of Iron and Transition Metal Micronutrients to Diabetes and Metabolic Disease Chapter 16The Role of Gut Microbiota in the Pathogenesis and Treatment of Diabetes Chapter 17Achieving a Healthy Body Weight in Later Life: Interventions to Reduce Type 2 Diabetes Risk Chapter 18Primary Prevention of Type 2 Diabetes: From Research to Community Chapter 19Management of Diabetes Mellitus in Sub-Saharan Africa: Focus on Nigeria Chapter 20Gestational Diabetes: Focus on Pregestational, Gestational, and Postnatal Weight Management Chapter 21Pathophysiology and Management of Type 1 Diabetes: Rational Design of Insulin Therapy Chapter 22Meal Detection Module in an Artificial Pancreas System for People with Type 1 Diabetes Chapter 23Oxidative Stress and the Effects of Dietary Supplements on Glycemic Control in Type 2 Diabetes Chapter 24Management of Diabetic Gastroparesis